Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
1.
Eur J Clin Microbiol Infect Dis ; 26(3): 195-8, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17393202

RESUMO

Reported here are the microbiological and epidemiological details of a presumed outbreak of aerobic gram-negative bacilli infections affecting 19 hematological patients, which was traced to contaminated disinfectant. Over a 5-month period, the following organisms were isolated from the blood cultures of 19 neutropenic patients: Pseudomonas fluorescens (n = 13), Achromobacter xylosoxidans (n = 12), Comamonas testosteroni (n = 2) or Stenotrophomonas maltophilia (n = 1). The affected patients were all treated with an expensive regimen of broad-spectrum antibiotic therapy. The same bacteria were recovered from environmental samples as well as from the water pipes of an apparatus for dispensing disinfectant (didecyldimethylammonium chloride). Genotyping results indicated that many of the clinical strains were identical to strains isolated from the apparatus. It was eventually discovered that the night staff was in the habit of disinfecting the blood-culture bottles before use, thereby contaminating the bottles with bacteria contained in the disinfectant. Contamination of the apparatus resulted from faulty maintenance.


Assuntos
Bacteriemia/epidemiologia , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/microbiologia , Desinfetantes , Contaminação de Medicamentos , Bactérias Aeróbias Gram-Negativas/isolamento & purificação , Infecções por Bactérias Gram-Negativas/epidemiologia , Bacteriemia/etiologia , Bacteriemia/microbiologia , Infecção Hospitalar/etiologia , Surtos de Doenças , Embalagem de Medicamentos , Eletroforese em Gel de Campo Pulsado/métodos , Bactérias Aeróbias Gram-Negativas/crescimento & desenvolvimento , Infecções por Bactérias Gram-Negativas/etiologia , Infecções por Bactérias Gram-Negativas/microbiologia , Neoplasias Hematológicas/tratamento farmacológico , Neoplasias Hematológicas/microbiologia , Humanos , Abastecimento de Água
3.
Z Kardiol ; 92(8): 668-76, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12955414

RESUMO

In patients with coronary artery disease undergoing noncardiac surgery, beta-blockers decrease perioperative mortality and nonfatal myocardial infarction. It is presently unknown whether beta-blockers reduce perioperative risk in patients with chronic heart failure. Thus, data of the CIBIS II study were analyzed regarding the effect of bisoprolol on perioperative outcome in patients with moderate to severe heart failure. A total of 2647 patients with heart failure in New York Heart Association (NYHA) class III-IV and left ventricular ejection fraction < or =35% were randomized to bisoprolol or placebo in a double-blind randomized study. Of these patients, 165 underwent surgery (bisoprolol, n = 87; placebo, n = 78). In patients undergoing surgery, mortality was not different between the placebo- and bisoprolol-treated group (7.7% vs 5.8%, p = 0.76). Neither postoperative hospital admission (placebo, 24.4%; bisoprolol, 34.5%, p = 0.17) nor time to postoperative hospital admission (placebo, < or =30 days, n = 2; 31-180 days, n=11; >180 days, n = 6; bisoprolol, n = 9/ 10/11; p = 0.14) were reduced by bisoprolol. Compared to coronary artery disease, perioperative beta-blockade has little effect in patients with chronic heart failure. Therefore, a controlled randomized trial with perioperative beta-blocker treatment in heart failure patients is warranted to further test this hypothesis.


Assuntos
Antagonistas Adrenérgicos beta/farmacologia , Bisoprolol/farmacologia , Insuficiência Cardíaca/complicações , Complicações Intraoperatórias/prevenção & controle , Procedimentos Cirúrgicos Operatórios , Antagonistas Adrenérgicos beta/administração & dosagem , Antagonistas Adrenérgicos beta/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Bisoprolol/administração & dosagem , Bisoprolol/uso terapêutico , Interpretação Estatística de Dados , Método Duplo-Cego , Feminino , Insuficiência Cardíaca/tratamento farmacológico , Insuficiência Cardíaca/mortalidade , Hospitalização , Humanos , Complicações Intraoperatórias/mortalidade , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Placebos , Fatores de Risco , Volume Sistólico , Procedimentos Cirúrgicos Operatórios/mortalidade , Fatores de Tempo , Resultado do Tratamento
4.
Minerva Chir ; 56(3): 303-6, 2001 Jun.
Artigo em Italiano | MEDLINE | ID: mdl-11423798

RESUMO

The case of a 59 year-old patient, who sustained a post-traumatic fracture of the silastic catheter of his totally implantable venous access device that migrated in the right pulmonary artery, is reported. The venous device was placed six months earlier for the treatment of metastatic spread of a primary unknown adenocarcinoma. The venous device was placed on the left side in consideration of a recent right supraclavicular node biopsy. The catheter was introduced through the left internal jugular vein and its peripheral end was positioned subcutaneously across the clavicle to be connected to the port chamber placed in the infraclavicular region. The accidental fracture of the catheter was attributed to a closed trauma occurred during the transport of a refrigerator on the homolateral shoulder. Treatment involved extraction of the migrated fragment through a percutaneous transfemoral angioradiological procedure. A few days later the chamber was removed and a new totally implantable venous access device was placed on the other side.


Assuntos
Cateterismo Venoso Central , Cateteres de Demora/efeitos adversos , Migração de Corpo Estranho/etiologia , Artéria Pulmonar , Ferimentos não Penetrantes , Humanos , Masculino , Pessoa de Meia-Idade
5.
Circulation ; 103(10): 1428-33, 2001 Mar 13.
Artigo em Inglês | MEDLINE | ID: mdl-11245648

RESUMO

BACKGROUND: beta-Blockade-induced benefit in heart failure (HF) could be related to baseline heart rate and treatment-induced heart rate reduction, but no such relationships have been demonstrated. METHODS AND RESULTS: In CIBIS II, we studied the relationships between baseline heart rate (BHR), heart rate changes at 2 months (HRC), nature of cardiac rhythm (sinus rhythm or atrial fibrillation), and outcomes (mortality and hospitalization for HF). Multivariate analysis of CIBIS II showed that in addition to beta-blocker treatment, BHR and HRC were both significantly related to survival and hospitalization for worsening HF, the lowest BHR and the greatest HRC being associated with best survival and reduction of hospital admissions. No interaction between the 3 variables was observed, meaning that on one hand, HRC-related improvement in survival was similar at all levels of BHR, and on the other hand, bisoprolol-induced benefit over placebo for survival was observed to a similar extent at any level of both BHR and HRC. Bisoprolol reduced mortality in patients with sinus rhythm (relative risk 0.58, P:<0.001) but not in patients with atrial fibrillation (relative risk 1.16, P:=NS). A similar result was observed for cardiovascular mortality and hospitalization for HF worsening. CONCLUSIONS: BHR and HRC are significantly related to prognosis in heart failure. beta-Blockade with bisoprolol further improves survival at any level of BHR and HRC and to a similar extent. The benefit of bisoprolol is questionable, however, in patients with atrial fibrillation.


Assuntos
Bisoprolol/uso terapêutico , Cardiopatias/tratamento farmacológico , Frequência Cardíaca/efeitos dos fármacos , Antagonistas Adrenérgicos beta/farmacologia , Antagonistas Adrenérgicos beta/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Bisoprolol/farmacologia , Pressão Sanguínea/efeitos dos fármacos , Doença Crônica , Feminino , Cardiopatias/mortalidade , Cardiopatias/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Mortalidade , Análise Multivariada , Taxa de Sobrevida , Fatores de Tempo
6.
Am J Clin Oncol ; 23(3): 288-9, 2000 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10857895

RESUMO

We report the results of a chemotherapy regimen combining oxaliplatin, 5-fluorouracil, and folinic acid in patients with metastatic renal cell carcinoma. The objective of this pilot study was to define the potential efficacy of this second-line combination in patients previously treated with interleukin-2 alone or in combination with interferon alpha. Fourteen patients with metastatic renal cell carcinoma in failure after immunotherapy were included in this trial. During treatment, patients received six chemotherapy courses (Folfox regimen) administered every 2 weeks. Each cycle combined oxaliplatin day (D) D1 and folinic acid plus 5-fluorouracil D1 and D2. At completion of treatment, no objective response was observed and two patients presented stable disease. This chemotherapy schedule in patients with metastatic renal cell carcinoma previously treated with immunotherapy does not seem to be effective.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Carcinoma/tratamento farmacológico , Neoplasias Renais/tratamento farmacológico , Idoso , Carcinoma/secundário , Feminino , Fluoruracila/administração & dosagem , Humanos , Imunoterapia , Interferon-alfa/uso terapêutico , Interleucina-2/uso terapêutico , Neoplasias Renais/secundário , Leucovorina/administração & dosagem , Masculino , Pessoa de Meia-Idade , Compostos Organoplatínicos , Projetos Piloto , Prognóstico
7.
Leukemia ; 14(12): 2085-94, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11187897

RESUMO

Overexpression of P-glycoprotein (P-gp) in cancer cells reduces intracellular accumulation of various anticancer drugs including anthracyclines and vinca alkaloids. This multidrug resistance (MDR) phenotype can be reversed in vitro by a number of non-cytotoxic drugs. We have identified the quinine's isomer cinchonine as a potent MDR reversing agent, both in vitro and in animal models. Here, we report an open phase I dose escalation trial in patients with refractory or relapsed malignant lymphoid diseases. Cinchonine dihydrochloride was administered by continuous i.v. infusion for 48 h and escalated over five dose levels ranging from 15 to 35 mg/kg/d. Cinchonine infusion started 24 h before i.v. doxorubicin (25 mg/m2), vinblastine (6 mg/m2), cyclophosphamide (600 mg/m2) and methylprednisolone (1 mg/kg/d) (CHVP regimen) and lasted for 24 h after chemotherapy infusion. Thirty-four patients received 87 cycles of CHVP/cinchonine. The MTD of cinchonine administered by continuous i.v. infusion was 30 mg/kg/d. Prolonged cardiac repolarization was the main dose-limiting toxicity. No ventricular arrhythmia including 'torsade de pointes' was observed. An MDR reversing activity was identified in the serum from every patient and correlated with cinchonine serum level. When infused at 30 mg/kg/d, cinchonine demonstrated a limited influence on doxorubicin pharmacokinetic. We conclude that i.v. infusion of cinchonine might be started 12 h before MDR-related chemotherapy infusion and requires continuous cardiac monitoring but no reduction of cytotoxic drug doses.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Alcaloides de Cinchona/uso terapêutico , Resistência a Múltiplos Medicamentos , Resistencia a Medicamentos Antineoplásicos , Transtornos Linfoproliferativos/tratamento farmacológico , Adulto , Idoso , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Alcaloides de Cinchona/efeitos adversos , Alcaloides de Cinchona/farmacocinética , Ciclofosfamida/administração & dosagem , Doxorrubicina/administração & dosagem , Eletrocardiografia , Feminino , Coração/efeitos dos fármacos , Humanos , Leucopenia/induzido quimicamente , Masculino , Pessoa de Meia-Idade , Prednisona/administração & dosagem , Recidiva , Teniposídeo/administração & dosagem
8.
Artigo em Francês | MEDLINE | ID: mdl-9265043

RESUMO

Early menopause due to an exhaustion of the ovarian follicles before the age of 40 years occurs in approximately 1% of women in this age range. Clinical signs of estrogen deficiency with amenorrhea and sterility are usually confirmed by hypergonadotrope hypogonadism at laboratory tests. The syndrome is to be differentiated from gonadotrophine resistant ovaries and rare gonadotrope adenomas. Ovary biopsy shows more or less complete destruction of the follicles. There are many causes of early menopause including abnormal number or structure of chromosome X in 15-20% of the cases. Certain metabolic disorders and viral infections can also be incriminated. Finally surgery, radiotherapy or chemotherapy can be the cause of iatrogenic menopause. To determine prognosis, the woman's follicular capacity must be estimated. Estrogen therapy is currently the best choice to preserve chances for ovulation and pregnancy. When there is no remaining follicular capacity, ovum donation may be a solution. Finally, all patients should be given hormone substitution therapy due to the long-term risk of estrogen-progesterone deficiency.


Assuntos
Menopausa Precoce , Biópsia , Diagnóstico Diferencial , Terapia de Reposição de Estrogênios , Feminino , Humanos , Incidência , Menopausa Precoce/efeitos dos fármacos , Menopausa Precoce/fisiologia , Doação de Oócitos , Gravidez , Resultado da Gravidez , Prognóstico , Fatores de Risco
9.
Contracept Fertil Sex ; 24(11): 852-5, 1996 Nov.
Artigo em Francês | MEDLINE | ID: mdl-8991590

RESUMO

We carried out orthotopic autografts of ovarian tissue on 15 Wistar rats. One ovary has been removed and cut in 2 or 3 slices. The other ovary has been removed, and the controlateral slices grafted in the empty ovarian bursa by mean of a microscope, without vascular anastomosis. The endocrine function of the graft was assessed by checking the vaginal smears. The animals were mated. Two of them became pregnant with normal offsprings, two others has vaginal bleeding which could be miscarriages. This experimentation suggests that the orthotopic autograft of ovarian slices is possible in rats. The endocrine function of the ovary is restored with a very good rate. Fertility is restored for a small proportion of animals.


Assuntos
Ovário/transplante , Prenhez , Transplante Autólogo/métodos , Animais , Feminino , Fertilidade , Ovário/fisiologia , Gravidez , Resultado da Gravidez , Ratos , Ratos Wistar , Esfregaço Vaginal
10.
Eur J Obstet Gynecol Reprod Biol ; 68(1-2): 147-54, 1996 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8886698

RESUMO

OBJECTIVE: A report is given of a series of 126 laparoscopically-assisted vaginal hysterectomies (LAVH) for benign lesions, carried out between September 1990 and December 1995. MATERIALS AND METHOD: The mean age of the patients was 50.3 years, and the main indications for hysterectomy were metrorrhagia (88). The main reasons why LAVH was chosen from among other hysterectomy techniques were a large uterus (55), associated ovarian surgery (45), and a difficult vaginal approach (35). The surgical technique always began with a laparoscopic stage followed by a vaginal stage. The laparoscopic stage generally finished at the lower part of the broad ligament. The vagina was opened and the uterine arteries were ligatured by a vaginal approach (116). Only 10 total laparoscopic hysterectomies were performed. RESULTS: The mean duration of the operation was 72 +/- 28 min, mean blood loss was 1.89 g/dl, and mean uterus weight was 224 g (maximum = 1093 g). Operative complications consisted of two bladder wounds and two switches to abdominal hysterectomy. Postoperative complications were urinary infections (17), hemorrhages needing second-look operations [2] and abscess of the vaginal section requiring evacuation [3]. CONCLUSION: LAVH should never be carried out instead of vaginal hysterectomy (VH), since VH is the best procedure when it is easy to perform. The authors use LAVH when VH is difficult or contraindicated (the aim being to avoid laparotomy) and actually carry out less than 5% of hysterectomies for benign lesions by laparotomy.


Assuntos
Histerectomia/métodos , Laparoscopia , Doenças Uterinas/cirurgia , Perda Sanguínea Cirúrgica , Feminino , Humanos , Histerectomia/efeitos adversos , Laparoscopia/efeitos adversos , Pessoa de Meia-Idade , Complicações Pós-Operatórias , Fatores de Tempo , Bexiga Urinária/lesões
11.
Rev Fr Gynecol Obstet ; 90(1): 5-11, 1995 Jan.
Artigo em Francês | MEDLINE | ID: mdl-7899774

RESUMO

The origins of the Cesarian section date back to the Classical era, and possible even earlier. Ancient India, the Hebrews, the Grecks and the Romans were all familiar with post-mortem Cesarian section. The operation marked time during the Middle Ages. The name "Cesarian section" was first used to designate this operation during the Renaissance period, when it was first carried out in live women. However, until the middle of XIX th century, a Cesarian remained a last chance option which was cautioned against by most obstetricians. It was only after the advent of the "surgical golden tripod" that the Cesarian was gradually rehabilitated through the work of Poro, Kherer and Sanger and the German School. In the XIXth century, segmental incision became the norm and fetal indications for a Cesarian emerged.


Assuntos
Cesárea/história , Mundo Árabe , Cesárea/métodos , Feminino , Grécia , História do Século XVI , História do Século XVII , História do Século XVIII , História do Século XIX , História do Século XX , História Antiga , História Medieval , Humanos , Índia , Judeus , Gravidez , Mundo Romano
13.
Artigo em Francês | MEDLINE | ID: mdl-8051358

RESUMO

We studied the different motivations mothers had for choosing a particular mode of nursing at the University Hospital in Limoges. An anonymous questionnaire was distributed to all mothers who hat delivered between January 1 and April 30, 1992. It was apparent that the medical team did little to promote breast-feeding or to counteract negative attitudes. The results of this study, together with a review of the literature were used to determine conditions for encouraging breast feeding.


Assuntos
Alimentação com Mamadeira , Aleitamento Materno , Comportamento de Escolha , Mães/psicologia , Motivação , Atitude do Pessoal de Saúde , Feminino , Promoção da Saúde , Humanos , Inquéritos e Questionários , Fatores de Tempo
14.
Ann Otolaryngol Chir Cervicofac ; 110(5): 291-5, 1993.
Artigo em Francês | MEDLINE | ID: mdl-8304703

RESUMO

A case of rhabdomyosarcoma of the tongue in an adult male is reported. The diagnosis of this rare lesion is difficult and should be considered in every growing mass of the head and neck region. It is based on the pathologic examination of tissue samples guided by immunohistological methods. In this case the examination revealed an embryonal type. The tumoral progression is rapidly fatal unless an aggressive therapeutic regimen including surgery and radiotherapy is instituted. In this manner dramatic improvement in survival rate has been achieved in recent years.


Assuntos
Rabdomiossarcoma/patologia , Neoplasias da Língua/patologia , Adulto , Terapia Combinada , Humanos , Imuno-Histoquímica , Masculino , Estadiamento de Neoplasias , Prognóstico , Rabdomiossarcoma/terapia , Neoplasias da Língua/radioterapia
16.
Acta Gastroenterol Latinoam ; 16(2): 115-29, 1986.
Artigo em Espanhol | MEDLINE | ID: mdl-3554874

RESUMO

We present the case of a patient with a Vater's papilla carcinoid tumor treated with total duodenopancreatectomy followed by re-gastrectomy because of a second localization of the tumor in the gastrojejunal anastomoses. The patient remains asymptomatic after 3 years and 6 months survival. Digestive carcinoid tumors are described, analyzing their physiopathologic, clinical and prognostic aspects, having done a bibliographic revision of the item.


Assuntos
Ampola Hepatopancreática , Tumor Carcinoide/cirurgia , Neoplasias do Ducto Colédoco/cirurgia , Tumor Carcinoide/diagnóstico por imagem , Tumor Carcinoide/patologia , Neoplasias do Ducto Colédoco/diagnóstico por imagem , Neoplasias do Ducto Colédoco/patologia , Feminino , Humanos , Radiografia , Ultrassonografia
17.
Acta gastroenterol. latinoam ; 16(2): 115-29, 1986.
Artigo em Espanhol | BINACIS | ID: bin-52922

RESUMO

We present the case of a patient with a Vaters papilla carcinoid tumor treated with total duodenopancreatectomy followed by re-gastrectomy because of a second localization of the tumor in the gastrojejunal anastomoses. The patient remains asymptomatic after 3 years and 6 months survival. Digestive carcinoid tumors are described, analyzing their physiopathologic, clinical and prognostic aspects, having done a bibliographic revision of the item.

18.
Eur Neurol ; 23(5): 364-71, 1984.
Artigo em Inglês | MEDLINE | ID: mdl-6548969

RESUMO

The hypothesis for this therapeutic use of delta sleep-inducing peptide (DSIP) was based on several animal studies conducted by Tissot. He showed that morphine, alcohol, pentobarbital as well as DSIP, when injected directly into the bulbo-mesencephalo-thalamic recruiting system, induced slow-wave sleep with numerous spindles. In all cases, this effect was reversed by Naloxone. Thus, it has been postulated that DSIP possesses an agonistic activity on opiate receptors and might be of value in the treatment of withdrawal syndromes. Therefore, DSIP was administered intravenously to 107 inpatients presenting with symptoms of alcohol (n = 47) or opiate (n = 60) withdrawal. The assessment of effect was based on the clinical evaluation by the physician and the nursing staff. Approximately 13% of the patients from the first and 22% from the second group did not fulfil the requirements for the evaluation of treatment. In, respectively, 97 and 87% of opiate and alcohol addicts, the clinical symptoms and signs disappeared after DSIP administration or improved markedly and rapidly. Anxiety, however, was slower to decrease. On the average, the clinical symptomatology had a more prolonged course and a higher number of DSIP injections were required for opiate addicts than for alcoholics. Tolerance to the DSIP treatment was good, aside from headaches reported by a few patients.


Assuntos
Etanol/efeitos adversos , Entorpecentes/efeitos adversos , Oligopeptídeos/uso terapêutico , Síndrome de Abstinência a Substâncias/tratamento farmacológico , Adulto , Peptídeo Indutor do Sono Delta , Feminino , Heroína/efeitos adversos , Humanos , Injeções Intravenosas , Masculino , Metadona/efeitos adversos , Pessoa de Meia-Idade , Oligopeptídeos/administração & dosagem , Oligopeptídeos/efeitos adversos , Pentazocina/efeitos adversos
19.
Rev. argent. cir ; 46(6): 287-9, 1984.
Artigo em Espanhol | LILACS | ID: lil-22257

RESUMO

Se considera a la colecistoyeyunostomia como la derivacion quirurgica paliativa de eleccion para la ictericia en el cancer de la cabeza del pancreas. La asociacion de una gastroenteroanastomosis simultanea permite prevenir una eventual obstruccion duodenal por invasion neoplasica, la cual se presenta frecuentemente en la evolucion natural de la enfermedad. La presencia de litiasis vesicular no contraindica formalmente el uso de la vesicula biliar para la derivacion biliodigestiva


Assuntos
Pessoa de Meia-Idade , Humanos , Masculino , Feminino , Colecistectomia , Icterícia , Neoplasias Pancreáticas
20.
Rev. argent. cir ; 47(3/4): 99-101, 1984.
Artigo em Espanhol | LILACS | ID: lil-24790

RESUMO

Se presentan 3 casos de traumatismos cerrados toracoabdominales. Cuando se sospecha la existencia de uma herida hepatica, la laparotomia vertical ofrece la posibilidad de extender la incision al hemitorax derecho o de realizar una esternotomia mediana. En estos casos la reseccion hepatica se realiza por digitoclasia, pinzando los vasos hiliares. La mayor morbilidad registrada durante el post-operatorio se debe principalmente a problemas septicos.Los autores senalan la importancia de la tomografia axial computada que permite llegar al diagnostico etiologico y topografico temprano y en consecuencia al tratamiento efectivo de las eventuales complicaciones


Assuntos
Pré-Escolar , Adulto , Humanos , Masculino , Feminino , Traumatismos Abdominais , Hepatectomia , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...